• Sign In
    My Account
    • Edit Profile
    • Logout
Logo
  • Home
  • New low-volume, citrate-free formulation
    • New formulation overview
    • The patient injection experience
    • New formulation packaging
  • Indications
    • Safety profile
    • Contraindications
  • How to use
    • Pen
    • Syringe
    • Dosage
    • Storing and handling
  • Studies
    • Clinical trials
    • Phase I bioequivalence study
  • Supporting you and your patients
    • For HCPs
    • For your patients
  • Congresses and events

Select a country

  • Albania
  • Andorra
  • Austria
  • Belarus
  • Belgium
  • Bosnia and
    Herzegovina
  • Bulgaria
  • Croatia
  • Czech Republic
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Holy See
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Malta
  • Moldova
  • Monaco
  • Montenegro
  • Netherlands
  • North Macedonia
  • Norway
  • Poland
  • Portugal
  • Romania
  • Russia
  • San Marino
  • Serbia
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • Ukraine
  • United Kingdom
  • Other European Countries

Supporting you and
your patients

HCP
RESOURCES

PATlENT
RESOURCES

Imraldi low-volume, citrate-free formulation

New formulation overview

The patient injection experience

New formulation packaging

Indications

Safety profile

Contraindications

How to use

Pen

Syringe

Dosage

Storing and handling

Studies

Clinical trials

Phase I bioequivalence study

  • Supporting you and your patients
  • For HCPs
  • For your patients
  • Congresses and events

Social media

Linkedin/Twitter

biogen.com
Privacy Policy Terms and Conditions Cookies

This site is intended for EU healthcare professionals only.
Biogen - 183942.
Date of preparation:  February 2023.

Dosing Calculator
hidden buttton